A New Subtype of a Congenital Disorder of Glycosylation (CDG) with Mild Clinical Manifestations

B. Assmann; R. Hackler; V. Peters; J. R. Schaefer; T. Arndt; E. Mayatepek; J. Jaeken; G. F. Hoffmann

doi:10.1055/s-2001-20407

Neuropediatrics, Inhaltsverzeichnis

Neuropediatrics 2001; 32(6): 313-318
DOI: 10.1055/s-2001-20407

Original Article

Georg Thieme Verlag Stuttgart · New York

A New Subtype of a Congenital Disorder of Glycosylation (CDG) with Mild Clinical Manifestations

B. Assmann¹ [*] , R. Hackler² [*] , V. Peters¹ , J. R. Schaefer² , T. Arndt³ , E. Mayatepek¹ , J. Jaeken⁴ , G. F. Hoffmann¹

¹ University Children's Hospital, Division of Metabolic and Endocrine Diseases, Heidelberg, Germany
² University Hospital of Internal Medicine, Department of Cardiology, Marburg, Germany
³ bioscientia GmbH, Ingelheim, Germany
⁴ University Hospital, Centre for Metabolic Disease, Gasthuisberg, Leuven, Belgium

Abstract

Volltext

Referenzen

References

1 Acarregui M J, George T N, Rhead W J. Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. J Pediatr. 1998; 133 697-700
2 Altland K, Hackler R, Knoche W. Double one-dimensional electrophoresis of human serum transferrin: A new high-resolution screening method for genetically determined variation. Hum Genet. 1980; 54 221-231
3 Arndt T, Hackler R, Kleine T O, Gressner A M. Validation by isolelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay. Clin Chem. 1998; 44 27-34
4 Assmann B, Hoffmann G F, Köhler M, Hackler R, Kleine T O, Jaeken J. CDG-syndrome type 1 with normal phosphomannomutase activity and unusually mild clinical manifestations. Amino Acids. 1997; 12 387
5 Buist N, Grompe M, Steiner R, Miura Y, O'Brian J, Freeze H. Yet another congenital disorder of glycosylation! (CDGS). J Inherit Metab Dis. 2000; 23 (Suppl I) 187
6 Burda P, Borsig L, de Rijk-van Andel J, Wevers R, Jaeken J, Carchon H. et al . A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest. 1998; 102 647-652
7 Burlina A B, Bonafé L, Van Schaftingen E, Jaeken J. Congenital defects of glycosylation with retardation-dysmorphy syndrome and myopathic changes. J Inherit Metab Dis. 2000; 23 (Suppl I) 180
8 Carchon H A, Jaeken J. Determination of D-mannose in serum by capillary electrophoresis. Clin Chem. 2001; 47 1319-1321
9 Charlwood J, Clayton P, Johnson A, Keir G, Mian N, Winchester M, Winchester B. A case of the carbohydrate-deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase activity. J Inherit Metab Dis. 1997; 20 817-827
10 Cuer M, Barnier A, Durand G, Seta N. NaF-oxalate as a preservative of mannose in blood samples. Abstracts of “First International Workshop on CDGS”, Leuven, Belgium, November 12 - 14, 1999: 18.
11 de Koning T J, Dorland L, van Diggelen O P, Boonman A MC, de Jong G J, van Noort W L. et al . A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun. 1998; 245 38-42
12 De Praeter C M, Gerwig G J, Bause E, Nuytinck L K, Vliegenthardt J FG, Breuer W. et al . A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet. 2000; 66 1744-1756
13 Dorland L, De Koning T J, Toet M, De Vries L S, van den Berg I ET, Poll-The B T. Recurrent non-immune hydrops fetalis associated with carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis. 1997; 20 (Suppl I) 88
14 Durand G, Seta N. Protein glycosylation and diseases: Blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem. 2000; 46 795-805
15 Grünewald S, Schollen E, van Schaftingen E, Jaeken J, Matthijs G. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). Am J Hum Genet. 2001; 68 347-354
16 Hackler R, Arndt T, Kleine T O, Gressner A M. Effect of separation conditions on automated isoelectric focusing of carbohydrate-deficient transferrin and other human isotransferrins using the PhastSystem. Anal Biochem. 1995; 230 281-289
17 Hackler R, Arndt T, Peters V, Assmann B, Hoffmann G F, Steinmetz A. Automated isoelectric focusing of serum isotransferrins for laboratory diagnosis of carbohydrate-deficient glycoprotein syndrome using the PhastSystem TM. Scand J Clin Lab Invest. 1998; 58 (Suppl 228) 66-67
18 Hagberg B A, Blennow G, Kristiansson B, Stibler H. Carbohydrate-deficient glycoprotein syndromes: Peculiar group of new disorders. Pediatr Neurol. 1993; 9 255-262
19 Hanefeld F, Körner C, Holzbach-Eberle U, von Figura K. Congenital disorder of glycosylation-Ic: case report and genetic defect. Neuropediatrics. 2000; 31 60-62
20 Huemer M, Huber W-D, Schima W, Moeslinger D, Holzbach U, Wevers R. et al . Budd-Chiari syndrome associated with coagulation abnormalities in a child with carbohydrate deficient glycoprotein syndrome type Ix. J Pediatr. 2000; 136 691-695
21 Imbach T, Schenk B, Schollen E, Burda P, Stutz A, Grünewald S. et al . Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest. 2000; 105 233-239
22 Jaeken J, Artigas J, Barone R, Fiumara A, de Koning T J, Poll-The B T. et al . Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins. J Inherit Metab Dis. 1997; 20 447-449
23 Jaeken J, Carchon H, Stibler H. The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?. Glycobiology. 1993; 3 423-428
24 Jaeken J, Matthijs G, Saudubray J-M, Dionisi-Vici C, Bertini E, de Lonlay P. et al . Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet. 1998; 62 1535-1539
25 Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucsoaminyltransferase II. Arch Dis Child. 1994; 71 123-127
26 Jaeken J, Stibler H, Hagberg (eds) B. The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement. Acta Paediatr Scand. 1991; Suppl 375
27 Keir G, Winchester B G, Clayton P. Carbohydrate-deficient glycoprotein syndromes: Inborn errors of protein glycosylation. Ann Clin Biochem. 1999; 36 20-36
28 Kim S, Westphal V, Srikrishna G, Mehta D P, Peterson S, Filiano J. et al . Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J Clin Invest. 2000; 105 191-198
29 Körner C, Knauer R, Holzbach U, Hanefeld F, Lehle L, von Figura K. Carbohydrate-deficient glycoprotein syndrome type V: Deficiency of dolichyl-P-Glc:Man₉GlcNAc₂-PP-dolichyl glucosyltransferase. Proc Natl Acad Sci USA. 1998; 95 13200-13205
30 Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: Deficiency of dolichyl-P-Man ₅GlcNAc₂-PP-dolichyl mannosyltransferase. EMBO J. 1999; 18 6816-6822
31 Lübcke T, Marquardt T, von Figura K, Körner C. A new type of carbohydrate-deficient glycoprotein syndrome due to a decreased import of GDP-fucose into the Golgi. J Biol Chem. 1999; 274 25986-25989
32 Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman J-J, van Schaftingen E. Mutations in PMM2, a phosphomannomutase gene on chromosome 16 p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 1997; 16 88-92
33 Niehues R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch H G. et al . Carbohydrate-deficient glycoprotein syndrome type Ib - Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest. 1998; 101 1414-1420
34 Participants, “First International Workshop on CDGS”, Leuven, Belgium, November 12 - 13, 1999 . Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. Glycoconj J. 1999; 16 669-671
35 Quelhas D, Vilarinho L, Jaeken J. Carbohydrate deficient glycoprotein syndrome type I-Portugese experience. J Inherit Metab Dis. 2000; 23 (Suppl I) 183
36 Stibler H, Gylje H, Uller A. A neurodystrophic syndrome resembling carbohydrate-deficient glycoprotein syndrome type III. Neuropediatrics. 1999; 30 90-92
37 Stibler H, Holzbach U, Kristiansson B. Isoforms and levels of transferrin, antithrombin, α₁-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I. Scand J Clin Lab Invest. 1998; 58 55-61
38 Stibler H, Westerberg B, Hanefeld F, Hagberg B. Carbohydrate-deficient glycoprotein (CDG) syndrome - A new variant, type III. Neuropediatrics. 1993; 24 51-52
39 Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett. 1995; 377 318-320
40 Yamashita K, Ideo H, Ohkura T, Fukushima K, Yuasa I, Ohno K. et al . Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J Biol Chem. 1993; 268 5783-5789

1 The first two authors contributed equally to this work.

Dr. B. Assmann

Division of Metabolic and Endocrine Diseases, University Children's Hospital

Im Neuenheimer Feld 150

69120 Heidelberg

Germany

eMail: Birgit_Assmann@med.uni-heidelberg.de